The information in this section is intended for visitors outside the United States.
2 Rizountos & Thrakis Str.
167 77 Helliniko, Athens
Phone: +30 210 89 30 100
Fax: +30 210 96 18 260
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.
Gilead Hellas has been operating in Greece since December 1995. It was first established as NeXstar Pharmaceuticals Inc. and subsequently became Gilead Sciences Hellas M.EPE in 2001. Gilead's office in Athens provides sales, marketing, regulatory and medical support for our products throughout Greece and the Middle East.
In line with local Transparency Reporting requirements, Gilead is disclosing its interactions with HealthCare Professionals and HealthCare Organisations in Greece in the following report, supported by a Methodological Note. Enquiries about the report should be directed to: http://www.gilead.com/news/media-inquiries.
Gilead Sciences Greece EFPIA Report 2015
Gilead Sciences Greece EFPIA Methodological Note 2015 (in Greek)
In 2015 Gilead Hellas provided support via unrestricted educational and scientific grants and sponsorships to the following recipients. The information is correct at the time of writing (March 2016). The information is subject to change and will be updated accordingly. For a listing of previous years' grants, click here.
In 2015 Gilead Hellas provided support via the Asklepios Gilead Hellas Grants Programme to the following recipients. The information is correct at the time of writing (March 2016). The information is subject to change and will be updated accordingly.
This page is intended for visitors outside of the United States.